Eukaryotic Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

EC Accepts, published online ahead of print on 21 December 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
EC.00378-07v1
7/2/319    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frases, S.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frases, S.
Right arrow Articles by Casadevall, A.
Eukaryotic Cell doi:10.1128/EC.00378-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Cryptococcus neoformans CAPSULAR AND EXOPOLYSACCHARIDE FRACTIONS MANIFEST PHYSICAL, CHEMICAL AND ANTIGENIC DIFFERENCES

Susana Frases, Leonardo Nimrichter, Nathan B. Viana, Antonio Nakouzi, and Arturo Casadevall*

Department of Microbiology and Immunology, and Division of Infectious Diseases of the Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY, 10461, USA; Laboratório de Estudos Integrados em Bioquímica Microbiana, Instituto de Microbiologia Professor Paulo de Góes, LPO-COPEA, Instituto de Ciências Biomédicas, and Instituto de Física, Universidade Federal do Rio de Janeiro, 21941-590, Brazil

* To whom correspondence should be addressed. Email: casadeva{at}aecom.yu.edu.


   Abstract

The human pathogenic fungus Cryptococcus neoformans has a large polysaccharide (PS) capsule and releases copious amounts of PS into cultures and infected tissues. The capsular PS is a major virulence factor that can elicit protective antibody responses. PS recovered from culture supernatants has historically provided an ample and convenient source of material for structural and immunological studies. Two major assumptions in such studies are that the structural features of the exopolysaccharide material faithfully mirror those of capsular PS and that the isolation methods do not change PS properties. However, a comparison of exopolysaccharide made by two isolation techniques with capsular PS stripped from cells with gamma radiation or DMSO revealed significant differences in glycosyl composition, mass, size, charge, viscosity, circular dichroism spectra and reactivity with monoclonal antibodies (mAbs). Our results strongly suggest that exopolysaccharides and capsular PS are structurally different. A noteworthy finding was that polysaccharide made by Cetyl trimethylammonium bromide (CTAB) precipitation had larger mass and different conformation, than PS isolated by concentration and filtration, suggesting that the most commonly used methodology to purify GXM alters the PS. Hence, the method used to isolate PS can significantly influence the structural and antigenic properties of the product. Our findings have important implications for current views of the relationship between capsular and exopolysaccharides, for the generation of PS preparations suitable for immunological studies and for the formulation of PS-based vaccines for the prevention of cryptococcosis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Appl. Environ. Microbiol. Infect. Immun. J. Bacteriol.
Mol. Cell Biol. Microbiol. Mol. Biol. Rev. ALL ASM JOURNALS
Copyright © 2007 by the American Society for Microbiology.